Member Info for smithfields

You'd have thought that the company would have given the open offer a bit of support?...apparently not.

Theranos...was built on 'smoke and mirrors'...

https://www.msn.com/en-gb/money/other/how-this-billionaire-lost-everything-and-ended-up-in-jail/ss-BB1nW750?ocid=hpmsn&cvid=07fcbf99ba6b40a493f1aae98e4405b5&ei=9#image=18

It's only June 2024...at the moment, ie,H1.

1. Current consensus revenue is £6.45m for FY24. (Source: Bloomberg)

TwoGood2Die..... I'm sure those that invested here in the last placing are well aware of the cash burn rate.....there's no need for the continual mantra.

'...looks like a large PI buy or maybe even an institutional buy.'

It could be either...however, this is still in a closed period...so that limits the buyers...In view of the results out Friday...I'm going for increase stake building by existing holder. A buyer who was confident enough to splash out at 80p support is going for it.......(all my honest onion only)

'I can see the share price retracing back to 12p!'

Get your eyes tested and buy a pair of glasses.......you're suffering from blurred vision.(I hope you're not driving a car?)

TwoGood2Die....'Friday 6th of June'.....?....you can't even get the date right....'shape up or ship out'...preferable the latter.

From AFVFN...

https://angleplc.com/information-for-investors-angle-plc/financial-reports/

According to the article..results this coming Monday or Tuesday.

https://finance.yahoo.com/quote/AGL.L/

thanks to 's****y' advfn

https://twitter.com/tymeric7/status/1786680910781272521

Apologies if already posted..

https://www.thetimes.co.uk/article/astrazeneca-contract-puts-angle-in-spotlight-kwgj8s5j0

Results soon will tell us the true story...

Just look at the sells this morning...., dribs and drabs...it looks like DHSS money being gambled. Not exactly what it is meant for.

I hope those that followed TwoGood2die are thanking him this morning....what a plonker.

From the latest AZ Results........

They're doing a lot of work and research into breast cancer.....AGL's domain.

'US approvals for Tagrisso with the addition of chemotherapy for EGFRm NSCLC (FLAURA2), Enhertu in HER2-positive solid tumours (DESTINY-PanTumor02, DESTINY-Lung01, DESTINY-CRC02) and Ultomiris for NMOSD. US and EU approval for Voydeya as an add-on therapy to Ultomiris or Soliris for PNH with EVH (ALPHA). Japan approval for Truqap plus Faslodex in unresectable or recurrent PIK3CA-, AKT1-, or PTEN-altered HR-positive, HER2-negative breast cancer (CAPItello-291).

‒ Datopotamab deruxtecan BLAs accepted in the US for non-squamous NSCLC (TROPION-Lung01) and HR-positive, HER2-negative breast cancer (TROPION-Breast01)

ANGLE is also working to expand its DDR work with other large pharma customers and continues to generate significant new customer interest through its business development activity."

A placing with more hype........is doomed to fail.

Https://www.webull.com/quote/otcqx-anpcy

Look on the bright side....if they were going to raise money, they would have done it, at the higher price, before now.

'Anyone with a short position is going to get slaughtered IMHO. '

Let the market do its work.....MM's are very clever people.....they too have got to make money.